Readily Secures $11M for Compliance Intelligence Platform
The Series A round was led by Define Ventures, with participation from Y Combinator and the California Health Care Foundation Innovation Fund.
Why Epic Is Launching a Prescription Price Comparison Tool
Epic will launch a tool in summer 2027 to help patients compare prescription cash prices and insurance costs across pharmacies.
presented by
Top 7 Modern AI-Powered EAP Providers for Global Workforces in 2026
Discover the top AI-powered EAP providers for 2026. Compare platforms like Kyan Health and Spring Health on triage speed, global reach, and clinical quality to transform workforce wellbeing.
Rosarium Health Forms Home Modification Partnership with Anthem Medi-Cal
Rosarium Health partnered with Anthem Medi-Cal to provide home safety modifications for eligible members.
Medicare Policy Shouldn’t Be Made in the Shadows
Medicare policy should be transparent and include appropriate notice and stakeholder input. And when a contractor gets it wrong, there should be a clear and rapid way to stop the harm to patients, their relationship with their doctor and the doctor’s practice.
Pediatric Innovation Isn’t a Small-Market Problem, It’s an Incentive Problem
Investing in pediatric care is not simply a moral imperative. It is one of the most practical long-term investments the healthcare system can make.
Trilliant Health: Misaligned Incentives Are Undermining US Healthcare
Trilliant Health’s report identifies six trends highlighting how misaligned incentives are contributing to rising costs, poor health outcomes, workforce shortages and other systemic problems in U.S. healthcare.
presented by
The Healthcare Payments Industry Faces a Perception Challenge
Healthcare payments are no longer about transactions. It’s about controlling the revenue cycle. And increasingly, that control is not sitting with ISOs.
presented by
Constant Vigilance is the Watchword for Healthcare AI Governance
Sponsored by Cotiviti, a webinar addressing the challenges of AI implementation and governance offered insights based on findings from the Healthcare AI Readiness Index.
PBM Transparency Is Still Too Opaque — How Can Employers Rein In Drug Costs?
Employers are trying to comparison shop in a market where all the price tags are hidden. And most can’t simply switch PBMs to find better pricing for their members.
From Distributor to Disruptor: Amazon’s Healthcare Flex
No longer satisfied with buying pharmacies and clinics, it seems intent on owning the healthcare journey, and perhaps redrawing pharma’s commercialization map.
Hidden Risks and Costs of Maternal/Infant Health that Health Plans Miss
A new report from ProgenyHealth offers a window into how the business works with commercial and Medicaid plans to close gaps in maternity and NICU care management that traditional programs overlook.
Why Pharma Companies Should Look To Social Media For Better Patient Insight
Healthcare decision-makers, especially at pharmaceutical companies, must prioritize patient input. Data collected from social media listening is a significant step in the right direction.
Trump Administration Announces $90 Payments to Help Cover Medicare Part B Premiums
The Trump administration is issuing one-time $90 payments to more than 20 million Medicare beneficiaries to help cover Part B premiums, though the payments may do little to offset rising healthcare costs.
Trump’s ACA Fraud Crackdown: Experts Urge Going After Bad Actors, Not Patients
The Trump administration’s ACA fraud crackdown will remove 760,000 people from Marketplace coverage, drawing criticism from healthcare experts and advocates.
Debunked Episode 30: ACCESS Tries to Succeed Where VBC Fails, AI, and UnitedHealth Gets the Last Week Tonight Treatment
Debunked Podcast co-hosts Arundhati Parmar and Samir Batra discussed the merits of the CMS ACCESS Model (Advancing Chronic Care with Effective, Scalable Solutions) and how it can offer a path to advance value-based care goals.
AMA: PBM Market Concentration Is On the Rise
The AMA found that OptumRx, Express Scripts, CVS Caremark and Prime Therapeutics controlled 75% of the national PBM market in 2024.
Fifty Years of Pediatric Rheumatology, but Children Still Can’t Access the Treatments They Need
As a country, we have developed treatments capable of improving the quality of life and preventing long-term damage for children with rheumatic conditions, yet many children cannot obtain them when they need them most. This needs to change.